Back to search
Ketamine
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ketamine trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Ketamine trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Depression is a common condition, with serious negative effects on the health and quality of life of those affected. While there are currently various medicatio…
Background: Most medications that treat depression take weeks or months to work. Researchers want to develop fast-acting treatments. One dose of ketamine has a…
The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.
The goal of this naturalistic, open label, single arm intervention study is to investigate the effects of Esketamine in treating depression.The main aims to ans…
The goal of this clinical trial is to learn if ACP-211 can help treat adults with major depressive disorder (MDD) who have not improved with antidepressant ther…
In the treatment of Major Depressive Disorder (MDD), ketamine can produce rapid but short-lasting improvements in mood. In order to develop a new generation of…
This is a prospective, single center, double blind, randomized, crossover feasibility study of oral ketamine versus placebo for the treatment of anxiety in pati…
The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.